230 related articles for article (PubMed ID: 22996146)
1. Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors.
Vezzosi D; Libé R; Baudry C; Rizk-Rabin M; Horvath A; Levy I; René-Corail F; Ragazzon B; Stratakis CA; Vandecasteele G; Bertherat J
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2063-9. PubMed ID: 22996146
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.
Libé R; Fratticci A; Coste J; Tissier F; Horvath A; Ragazzon B; Rene-Corail F; Groussin L; Bertagna X; Raffin-Sanson ML; Stratakis CA; Bertherat J
Clin Cancer Res; 2008 Jun; 14(12):4016-24. PubMed ID: 18559625
[TBL] [Abstract][Full Text] [Related]
3. Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.
Libé R; Horvath A; Vezzosi D; Fratticci A; Coste J; Perlemoine K; Ragazzon B; Guillaud-Bataille M; Groussin L; Clauser E; Raffin-Sanson ML; Siegel J; Moran J; Drori-Herishanu L; Faucz FR; Lodish M; Nesterova M; Bertagna X; Bertherat J; Stratakis CA
J Clin Endocrinol Metab; 2011 Jan; 96(1):E208-14. PubMed ID: 21047926
[TBL] [Abstract][Full Text] [Related]
4. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population.
Horvath A; Giatzakis C; Robinson-White A; Boikos S; Levine E; Griffin K; Stein E; Kamvissi V; Soni P; Bossis I; de Herder W; Carney JA; Bertherat J; Gregersen PK; Remmers EF; Stratakis CA
Cancer Res; 2006 Dec; 66(24):11571-5. PubMed ID: 17178847
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer.
Faucz FR; Horvath A; Rothenbuhler A; Almeida MQ; Libé R; Raffin-Sanson ML; Bertherat J; Carraro DM; Soares FA; Molina Gde C; Campos AH; Alexandre RB; Bendhack ML; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2011 Jan; 96(1):E135-40. PubMed ID: 20881257
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.
Boikos SA; Horvath A; Heyerdahl S; Stein E; Robinson-White A; Bossis I; Bertherat J; Carney JA; Stratakis CA
Horm Metab Res; 2008 May; 40(5):347-53. PubMed ID: 18491255
[TBL] [Abstract][Full Text] [Related]
7. Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors.
Horvath A; Korde L; Greene MH; Libe R; Osorio P; Faucz FR; Raffin-Sanson ML; Tsang KM; Drori-Herishanu L; Patronas Y; Remmers EF; Nikita ME; Moran J; Greene J; Nesterova M; Merino M; Bertherat J; Stratakis CA
Cancer Res; 2009 Jul; 69(13):5301-6. PubMed ID: 19549888
[TBL] [Abstract][Full Text] [Related]
8. Rare inactivating PDE11A variants associated with testicular germ cell tumors.
Pathak A; Stewart DR; Faucz FR; Xekouki P; Bass S; Vogt A; Zhang X; Boland J; Yeager M; Loud JT; Nathanson KL; McGlynn KA; Stratakis CA; Greene MH; Mirabello L
Endocr Relat Cancer; 2015 Dec; 22(6):909-17. PubMed ID: 26459559
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP and c-KIT signaling in familial testicular germ cell tumor predisposition.
Azevedo MF; Horvath A; Bornstein ER; Almeida MQ; Xekouki P; Faucz FR; Gourgari E; Nadella K; Remmers EF; Quezado M; de Alexandre RB; Kratz CP; Nesterova M; Greene MH; Stratakis CA
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1393-400. PubMed ID: 23771924
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
Bimpaki EI; Nesterova M; Stratakis CA
Eur J Endocrinol; 2009 Jul; 161(1):153-61. PubMed ID: 19429701
[TBL] [Abstract][Full Text] [Related]
11. Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients.
Peverelli E; Ermetici F; Filopanti M; Elli FM; Ronchi CL; Mantovani G; Ferrero S; Bosari S; Beck-Peccoz P; Lania A; Spada A
Eur J Endocrinol; 2009 Nov; 161(5):687-94. PubMed ID: 19671705
[TBL] [Abstract][Full Text] [Related]
12. A phosphodiesterase 11 (Pde11a) knockout mouse expressed functional but reduced Pde11a: Phenotype and impact on adrenocortical function.
Levy I; Szarek E; Maria AG; Starrost M; De La Luz Sierra M; Faucz FR; Stratakis CA
Mol Cell Endocrinol; 2021 Jan; 520():111071. PubMed ID: 33127481
[TBL] [Abstract][Full Text] [Related]
13. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia.
Horvath A; Boikos S; Giatzakis C; Robinson-White A; Groussin L; Griffin KJ; Stein E; Levine E; Delimpasi G; Hsiao HP; Keil M; Heyerdahl S; Matyakhina L; Libè R; Fratticci A; Kirschner LS; Cramer K; Gaillard RC; Bertagna X; Carney JA; Bertherat J; Bossis I; Stratakis CA
Nat Genet; 2006 Jul; 38(7):794-800. PubMed ID: 16767104
[TBL] [Abstract][Full Text] [Related]
14. Functional characteristics and research trends of PDE11A in human diseases (Review).
Kong G; Lee H; Vo TT; Juang U; Kwon SH; Park J; Park J; Kim SH
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35929507
[TBL] [Abstract][Full Text] [Related]
15. Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds.
Gagliardi L; Hotu C; Casey G; Braund WJ; Ling KH; Dodd T; Manavis J; Devitt PG; Cutfield R; Rudzki Z; Scott HS; Torpy DJ
Clin Endocrinol (Oxf); 2009 Jun; 70(6):883-91. PubMed ID: 19018784
[TBL] [Abstract][Full Text] [Related]
16. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
[TBL] [Abstract][Full Text] [Related]
17. Familial micronodular adrenocortical disease, Cushing syndrome, and mutations of the gene encoding phosphodiesterase 11A4 (PDE11A).
Carney JA; Gaillard RC; Bertherat J; Stratakis CA
Am J Surg Pathol; 2010 Apr; 34(4):547-55. PubMed ID: 20351491
[TBL] [Abstract][Full Text] [Related]
18. Alterations of Phosphodiesterases in Adrenocortical Tumors.
Hannah-Shmouni F; Faucz FR; Stratakis CA
Front Endocrinol (Lausanne); 2016; 7():111. PubMed ID: 27625633
[TBL] [Abstract][Full Text] [Related]
19. The Sleep Quality- and Myopia-Linked PDE11A-Y727C Variant Impacts Neural Physiology by Reducing Catalytic Activity and Altering Subcellular Compartmentalization of the Enzyme.
Sbornova I; van der Sande E; Milosavljevic S; Amurrio E; Burbano SD; Das PK; Do HH; Fisher JL; Kargbo P; Patel J; Porcher L; De Zeeuw CI; Meester-Smoor MA; Winkelman BHJ; Klaver CCW; Pocivavsek A; Kelly MP
Cells; 2023 Dec; 12(24):. PubMed ID: 38132157
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.
Hsiao HP; Kirschner LS; Bourdeau I; Keil MF; Boikos SA; Verma S; Robinson-White AJ; Nesterova M; Lacroix A; Stratakis CA
J Clin Endocrinol Metab; 2009 Aug; 94(8):2930-7. PubMed ID: 19509103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
